Showing 351-360 of 4264 results for "".
Take 5 With Bobak Azamian, MD, PhD, Chief Executive Officer and Chairman of Tarsus Pharmaceuticals
https://practicaldermatology.com/columns/take-5/take-5-with-bobak-azamian-md-phd-chief-executive-officer-and-chairman-of-tarsus-pharmaceuticals/23982/Moving Toward a More Tolerable Treatment for AK
https://practicaldermatology.com/topics/general-topics/moving-toward-a-more-tolerable-treatment-for-ak/20760/A conversation with Peter Friedman, MD, PhD about non-thermal, atmospheric pressure plasma.Lift Off: Non-Invasive Skin Tightening
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/lift-off-non-invasive-skin-tightening/18223/Arisa Ortiz, MD says that minimally invasive devices won't approach surgical results, but patients can get significant improvement. She discusses patient selection, expectations, and outcomes with host Joel L. Cohen, MD.Hot Topics: Does Looking Natural Matter?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/hot-topics-does-looking-natural-matter/18206/What is a natural result? It's the number one concern patients have when they come into the office. Steven Dayan, MD and Joel L. Cohen, MD discuss the aim of cosmetic interventions.Topical Treatment Considerations for Psoriasis
https://practicaldermatology.com/topics/psoriasis/topical-treatment-considerations-for-psoriasis/18845/Jerry Bagel, MD and Neil J. Korman, MD discuss topical treatment options for treating patients with mild psoriasis. They share insights about the effect of vehicles on compliance, particularly when treating patients with scalp psoriasis.Clinical Conversations: How JAK Inhibitors are Changing the AD Treatment Landscape
https://practicaldermatology.com/series/jak-inhibitors-in-practice/clinical-conversations-how-jak-inhibitors-are-changing-the-ad-treatment-landscape/20092/With the approval of JAK inhibitors to treat eczema, the treatment landscape is changing. Matt Zirwas, MD and Adelaide Hebert, MD talk about the role for JAK inhibitors and key considerations for discussing options with patients.The Gist of the JECK
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-gist-of-the-jeck/19727/Ava Shamban, MD talks to Joel Cohen, MD about the JECK (where the jawline blends into the neck), and the combination approach she has developed to improve the appearance of this area.Update on Keloids and Scarring
https://practicaldermatology.com/topics/general-topics/update-on-keloids-and-scarring/19267/Brian Berman, MD talks with host Joshua Zeichner, MD about the use of interferon and topical immune modulators for the management of keloids. What does the evidence show? What are optimal protocols?Active Vitiligo: What to Look For
https://practicaldermatology.com/series/updates-vitiligo/active-vitiligo-what-to-look-for/24156/John E. Harris, MD, founding director of the Autoimmune Therapeutics Institute at the University of Massachusetts Chan Medical School, talks with Practical Dermatology Chief Medical Editor Neal Bhatia, MD, about the clinical signs of active vitiligo.Family Affair
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/family-affair/19697/Fun, fresh, and scientific. That's how host Joel Cohen, MD describes CSF—now in its 11th year. Meeting founder Joel Schlessinger, MD weighs in on his vision for the meeting and what he learned this year.